LLY

Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014

[PR Newswire] – INDIANAPOLIS, April 6, 2014 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies – including bemaciclib beh meh sye’ klib (LY2835219), … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

U.S. judge upholds validity of Eli Lilly’s Alimta patent

[Reuters] – Eli Lilly was successful in a crucial legal battle on Monday when a U.S. District Judge in Indianapolis upheld the validity of its U.S. patent for the drugmaker’ s blockbuster lung-cancer drug, Alimta. The court said the defendants, Teva Phar moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who […]

U.S. District Court Upholds Validity of Lilly’s Alimta Patent Through 2022

[PR Newswire] – INDIANAPOLIS, March 31, 2014 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company’s favor regarding … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here […]

Eli Lilly & Co: Slowly Getting Back On Track

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

Better Buy: Eli Lilly & Co. or AstraZeneca plc?

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

Lilly Underwhelms Investors Again

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

9:33 am Eli Lilly: FDA issues Complete Response letter for Empagliflozin; FDA has not asked Boehringer Ingelheim to complete any new clinical trials to support the approval of the application

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

GLP-1 Race In Diabetes: Eli Lilly Vs. Competitors

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]